ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
trefostil
pierre fabre italia s.p.a. - minoxidil - minoxidil
neoperidys
pierre fabre pharma s.r.l. - domperidone - domperidone
permixon
pierre fabre pharma s.r.l. - repentina - repentina
immucytal
pierre fabre pharma s.r.l. - altri vaccini batterici - altri vaccini batterici
kerafilmver
pierre fabre italia s.p.a. - preparati per calli e verruche - preparati per calli e verruche
drill
pierre fabre pharma s.r.l. - clorexidina - clorexidina
roxolac
pierre fabre italia s.p.a. - ciclopirox - ciclopirox
tardyfer
pierre fabre pharma s.r.l. - ferro (ii) solfato - ferro (ii) solfato
tolerak
pierre fabre italia s.p.a. - fluorouracile - fluorouracile